Literature DB >> 6988263

Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment.

K Kosaka, T Kuzuya, Y Akanuma, R Hagura.   

Abstract

The changes in insulin response to a 100 g glucose tolerance test after treatment by diet, sulphonylurea and insulin were compared in non-ketotic diabetic patients who had fasting blood glucose concentrations higher than 160 mg/100 ml. Patients were selected so that their pre-treatment and post-treatment blood glucose levels were comparable between different treatment groups. Their insulin responses were poor initially but increased significantly when the diabetic state was improved by each treatment. The degree of improvement of insulin response was similar between different treatment groups, when their fasting blood glucose decreased below 140 mg/100 ml and the glucose tolerance curves were improved to a similar extent. Pre- and post-treatment sigma IRI values (sum of insulin values during glucose tolerance test, mean +/- SD) were 102 +/- 50 and 200 +/- 37 microU/ml in diet-treated group (n = 28), 90 +/- 40 and 195 +/- 53 microU/ml in sulphonylurea-treated group (n = 48), and 83 +/- 28 and 193 +/- 38 microU/ml in insulin-treated group (n = 13), respectively. The data suggest that the poor insulin response in overt diabetes results not only from an inherent insensitivity of B-cells to glucose but also from the metabolic derangement of diabetes. Poor insulin response and overtly diabetic metabolism seems to form a vicious cycle.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6988263     DOI: 10.1007/BF01228297

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  22 in total

1.  Prolonged suppression of insulin release by insulin-induced hypoglycemia: demonstration by C-peptide assay.

Authors:  D L Horwitz; A H Rubenstein; C Reynolds; G D Molnar; N Yanaihara
Journal:  Horm Metab Res       Date:  1975-11       Impact factor: 2.936

2.  Hyperinsulinemia and hypoinsulinemai. Insulin responses to oral carbohydrate over a wide spectrum of glucose tolerance.

Authors:  P J Savage; S E Dippe; P H Bennett; P Gorden; J Roth; N B Rushforth; M Miller
Journal:  Diabetes       Date:  1975-04       Impact factor: 9.461

3.  Insulin secretory response of diabetics during the period of improvement of glucose tolerance to normal range.

Authors:  K Kosaka; R Hagura; T Kuzuya; N Kuzuya
Journal:  Diabetologia       Date:  1974-12       Impact factor: 10.122

Review 4.  Appraisal of the extrapancreatic actions of sulfonylureas.

Authors:  J M Feldman; H E Lebovitz
Journal:  Arch Intern Med       Date:  1969-03

5.  The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy.

Authors:  P C Chu; M J Conway; H A Krouse; C J Goodner
Journal:  Ann Intern Med       Date:  1968-04       Impact factor: 25.391

6.  Effect of bonito insulin on endogenous insulin secretion in dogs.

Authors:  H Sando; Y Kanazawa; T Kuzuya
Journal:  Am J Physiol       Date:  1970-05

7.  An attempt to define the nature of chemical diabetes using a multidimensional analysis.

Authors:  G M Reaven; R G Miller
Journal:  Diabetologia       Date:  1979-01       Impact factor: 10.122

8.  Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide.

Authors:  G M Shenfield; A Logan; D Shirling; J Baird
Journal:  Diabetologia       Date:  1977-08       Impact factor: 10.122

9.  The effects of energy and carbohydrate restriction in patients with chronic diabetes mellitus.

Authors:  J R Perkins; T E West; P H Sönksen; C Lowy; C Iles
Journal:  Diabetologia       Date:  1977-12       Impact factor: 10.122

10.  betacell function during insulin or chlorpropamide treatment of maturity-onset diabetes mellitus.

Authors:  R C Turner; R R Holman
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

View more
  33 in total

1.  Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations.

Authors:  R P Robertson; H J Zhang; K L Pyzdrowski; T F Walseth
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

Review 2.  Effects of prolonged glucose stimulation on pancreatic beta cells: from increased sensitivity to desensitization.

Authors:  F Purrello; A M Rabuazzo; M Anello; G Patanè
Journal:  Acta Diabetol       Date:  1996-12       Impact factor: 4.280

Review 3.  Therapeutic dilemmas in type II diabetes mellitus--improving and maintaining beta-cell and insulin sensitivity.

Authors:  J H Karam
Journal:  West J Med       Date:  1988-06

Review 4.  Insulin therapy for type 2 diabetes.

Authors:  Afshin Sasali; Jack L Leahy
Journal:  Curr Diab Rep       Date:  2003-10       Impact factor: 4.810

5.  Duration of residual B-cell function in maturity-onset diabetes.

Authors:  M Cignarelli; M R Cospite; G Stefanelli; E Guastamacchia; G Nardelli; R Giorgino
Journal:  Acta Diabetol Lat       Date:  1984 Apr-Jun

6.  Islet beta cell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fatty rat: severe dysfunction with altered glycerolipid metabolism without steatosis or a falling beta cell mass.

Authors:  V Delghingaro-Augusto; C J Nolan; D Gupta; T L Jetton; M G Latour; M Peshavaria; S R Murthy Madiraju; E Joly; M-L Peyot; M Prentki; J Leahy
Journal:  Diabetologia       Date:  2009-03-18       Impact factor: 10.122

7.  Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes.

Authors:  P V Højberg; M Zander; T Vilsbøll; F K Knop; T Krarup; A Vølund; J J Holst; S Madsbad
Journal:  Diabetologia       Date:  2008-02-22       Impact factor: 10.122

8.  No glucotoxicity after 53 hours of 6.0 mmol/l hyperglycaemia in normal man.

Authors:  H Flax; D R Matthews; J C Levy; S W Coppack; R C Turner
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

Review 9.  Thiazolidinediones in prediabetes and early type 2 diabetes: what can be learned about that disease's pathogenesis.

Authors:  Jack L Leahy
Journal:  Curr Diab Rep       Date:  2009-06       Impact factor: 4.810

Review 10.  Early insulin use in type 2 diabetes: what are the cons?

Authors:  Jean-Louis Chiasson
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.